How big is Clover Health Investments Corp.?

As of Jun 18, Clover Health Investments Corp. has a market capitalization of $1.49 billion, with net sales of $0 million and a net profit of -$24.37 million. The company's balance sheet shows shareholder's funds of $341.14 million and total assets of $580.74 million.

As of Jun 18, Clover Health Investments Corp. has a market capitalization of 1,493.30 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 0.00 million for the latest four quarters, with a consolidated net profit of -24.37 million.<BR><BR>As of Dec 24, the company's balance sheet shows shareholder's funds of 341.14 million and total assets amounting to 580.74 million.

What does Clover Health Investments Corp. do?

Clover Health Investments Corp. is a micro-cap insurance company with a market cap of approximately $1.49 billion, currently reporting a net loss and no dividend yield. Key metrics indicate negative profitability and high debt levels.

Overview: <BR>Clover Health Investments Corp. operates in the insurance industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Net Profit: -1 Million (Quarterly Results - Mar 2025) <BR>Market Cap: USD 1,493.30 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -999,999.00 <BR>Return on Equity: -7.27% <BR>Price to Book: 4.44<BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Should I buy, sell or hold Clover Health Investments Corp.?

Is Clover Health Investments Corp. overvalued or undervalued?

Clover Health Investments Corp. is considered overvalued and risky due to its high Price to Book Value of 4.80, negative ROE of -7.27%, and underperformance with a 1-year return of 2.33% compared to the S&P 500's 17.14%.

As of 17 May 2021, Clover Health Investments Corp. moved from a grade of does not qualify to risky, indicating a deterioration in its valuation outlook. The company appears to be overvalued given its high Price to Book Value of 4.80 and an EV to Sales ratio of 0.98, which suggests that the market is pricing the stock at a premium relative to its sales performance. Additionally, the company's negative ROE of -7.27% further underscores its financial struggles.<BR><BR>In comparison to its peers, Clover Health's valuation metrics are concerning; for instance, Primerica, Inc. has a P/E ratio of 12.59 and Lincoln National Corp. boasts a much lower EV to EBITDA of 0.00, indicating that they are performing better in terms of profitability and valuation. The stock's recent performance shows a 1-year return of 2.33%, which is significantly lower than the S&P 500's return of 17.14%, reinforcing the notion that Clover Health is not only overvalued but also underperforming relative to the broader market.

Is Clover Health Investments Corp. technically bullish or bearish?

As of October 24, 2025, Clover Health Investments Corp. shows a mildly bullish technical trend, supported by positive weekly MACD and Bollinger Bands, despite mixed signals from daily moving averages and KST, while outperforming the S&P 500 recently but underperforming over the longer term.

As of 24 October 2025, the technical trend for Clover Health Investments Corp. has changed from sideways to mildly bullish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD is bullish. Bollinger Bands are bullish on both weekly and monthly time frames. The Dow Theory supports a mildly bullish outlook on both weekly and monthly charts. However, daily moving averages are mildly bearish, and the KST shows a mixed signal with weekly mildly bullish and monthly mildly bearish readings. The stock has outperformed the S&P 500 over the past week (40.96% vs. 1.92%) and month (18.63% vs. 2.32%), but has underperformed over the longer term, particularly in the past year (0.79% vs. 16.90%) and five years (-62.55% vs. 95.99%). Overall, the current technical stance is mildly bullish, driven by positive indicators in the weekly MACD, Bollinger Bands, and Dow Theory.